J.D. Power Finds Rising EV Home Charging Costs and Declining Satisfaction as Adoption of Smart Charging Remains Limited

J.D. Power Finds Rising EV Home Charging Costs and Declining Satisfaction as Adoption of Smart Charging Remains Limited

J.D. Power Study Highlights Challenges in EV Home Charging Experience Home charging continues to serve as the foundation of the electric vehicle ownership experience, accounting for approximately 86% of all…

Read MoreJ.D. Power Finds Rising EV Home Charging Costs and Declining Satisfaction as Adoption of Smart Charging Remains Limited
Experic Partners with Flurry Powders to Advance Spray-Dried Inhalation and Nasal Drug Development

Experic Partners with Flurry Powders to Advance Spray-Dried Inhalation and Nasal Drug Development

Experic and Flurry Powders Announce Strategic Collaboration Experic, a contract development and manufacturing organization (CDMO) specializing in pharmaceutical powder handling, spray drying, and clinical manufacturing services, has announced a strategic…

Read MoreExperic Partners with Flurry Powders to Advance Spray-Dried Inhalation and Nasal Drug Development
Oil States International Announces Retirement of Cindy Taylor and Names Lloyd Hajdik as CEO Effective May 1, 2026

Oil States International Announces Retirement of Cindy Taylor and Names Lloyd Hajdik as CEO Effective May 1, 2026

Oil States International Announces CEO Transition and Leadership Succession Plan Oil States International has officially announced that Cindy Taylor, the company’s President and Chief Executive Officer, has informed the Board…

Read MoreOil States International Announces Retirement of Cindy Taylor and Names Lloyd Hajdik as CEO Effective May 1, 2026
Wilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware

Wilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware

Wilmington PharmaTech Announces Major Expansion to Strengthen U.S. API Manufacturing Wilmington PharmaTech, a leading U.S.-based contract research, development, and manufacturing organization specializing in complex custom small-molecule active pharmaceutical ingredient production,…

Read MoreWilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware